Oral methotrexate and vaginal misoprostol for early abortion

Contraception

Volumn 54, Issue 1, 1996, Pages 15-18

  Creinin, Mitchell D ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

medical abortion; methotrexate; misoprostol

Indexed keywords

METHOTREXATE; MISOPROSTOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; MUSCLE CRAMP; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; VAGINA BLEEDING; VERTIGO;

EID: 0030199825     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(96)00113-8     Document Type: Article

References (12)

1. 1. Creinin MD, Darney PD. Methotrexate and misoprostol for early abortion. Contraception 1993;48:339-48.
2. 2. Creinin MD, Vittinghoff E. Methotrexate and misoprostol versus misoprostol alone for early abortion: a randomized controlled trial. JAMA 1994;272:1190-5.
3. 3. Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. Methotrexate and misoprostol for early abortion: a randomized trial comparing misoprostol 3 days and 7 days following methotrexate. Am J Obstet Gynecol 1995; 173:1578-84.
4. 4. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. New Engl J Med 1995;333:537-40.
5. 5. Schaff EA, Eisinger SH, Franks P, Kim SS. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med 1995;4:774-9.
6. 6. Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy. Contraception 1996;53:321-7.
7. 7. Office of Occupational Medicine, Directorate of Technical Support, Occupational Safety and Health Administration, U.S. Department of Labor. Work Practice Guidelines for Personnel Dealing with Cytotoxic (Antineoplastic) Drugs. OSHA Instruction PUB 8-1.1., January 29, 1986.
8. 8. Halprin KM, Fukui K, Ohkawara A. Blood levels of methotrexate and the treatment of psoriasis. Arch Derm 1971;103:243-9.
9. 9. Henderson ES, Adamson RH, Oliverio VT. The metabolic fate of titrated methotrexate. II. Absorption and excretion in man. Cancer Res 1965;25:1018-24.
10. 10. Oguey D, Kölliker F, Gerber NJ, Reichen J. Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis. Arthrit Rheumat 1992;35:611-4.
11. 11. Stuart JFB, Calman KC, Watters J, et al. Bioavailability of methotrexate: implications for clinical use. Cancer Chemother Pharmacol 1979;3:239-41.
12. 12. Goldstein S. Embryonic ultrasonographic measurements: crown-rump length revisited. Am J Obstet Gynecol 1991;165:497-501.